Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Disease

Libya floods: appeals for body bags amid fears of disease ‘epidemic’

Mayor of flood-hit city of Derna calls for body-recovery teams as international aid starts to arrive

The Guardian - AU

Mark Zuckerberg and Dr. Priscilla Chan's plan to prevent, cure, and manage all diseases by 2100

“We’re in a place in science where we can look at mutations, and we can look at the end state of what happens in disease,” Chan said. “The middle is, largely, a complete mystery.”

Fortune

When and where can you get the updated COVID booster? And who needs one? What you need to know, according to experts

All Americans ages 6 months and older are eligible for the new jabs, the CDC said Tuesday.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Unified approach: On the Nipah outbreak in Kerala and a One Health approach

As governments mount strategic efforts to control outbreaks and deaths due to infectious diseases, Kerala needs to initiate a One Health approach, looking ahead

The Hindu

Nipah: Studies on the ecological dynamics of NiV and disease epidemiology crucial

In 2019, when Nipah surfaced in the State for a second consecutive year, experts had warned that given the omnipresence of the Pteropus medius species of bats, found to be the key reservoirs of Nipah virus (NiV) across the State, Kerala should probably expect annual outbreaks of Nipah, and not…

The Hindu

Nipah virus outbreak in India: What you need to know about viral disease

India’s southern Kerala state issues alerts after two people died from the disease in the fourth outbreak since 2018.

Al Jazeera

JNCASR scientists find potential treatment route for Alzheimer’s disease

JNCASR scientists have discovered that plant-based polyphenols can modulate the ferroptosis-AD axis, providing a safe, cost-effective strategy for combating Alzheimer's. The study published in 'Chemical Sciences' presents a new dimension for drug development, with potential to inspire medicinal chemists to explore natural compounds for enhanced efficacy against AD.

The Hindu

Read news from The Economist, FT, and more,
with one subscription

President virtually launches Ayushman Bhav campaign

Pres. Murmu virtually launched Ayushman Bhav campaign & portal to achieve UHC & ensure healthcare for all. Multi-ministerial approach & involvement of local governance praised. Seva Pakwada initiative to ensure everyone receives essential health services. Ayushman Bhav to facilitate access of cards, IDs & raise awareness of diseases. Digital inclusion…

The Hindu

3 A-Rated Pharma Stocks to Buy Today

The pharmaceutical industry is expected to grow in the upcoming years, propelled by continual advancements in medicine, aiming to meet the escalating demands for chronic disease treatment and address the needs of an aging population. Therefore, quality pharma stocks Neurocrine Biosciences (NBIX), AbbVie Inc. (ABBV), and Novo Nordisk A/S (NVO),…

StockNews.com

For sickle cell patients, an elusive disability certificate

When SCD was included in the list of disabilities under the Rights of Persons with Disabilities Act, 2016, patients could only avail disability certificates with a one-year validity.

The Hindu

Do new Alzheimer's drugs actually help?

Fast-track approval of three risky drugs intends to slow the disease, but evidence they benefit patients is shaky

Salon

‘An epidemic’: Syphilis rages through Texas, causing newborn cases to climb amid treatment shortage

Syphilis rates in Texas continue to climb, alarming healthcare workers who see the highest increases among pregnant people and newborns. A shortage of treatment is complicating efforts to combat it.

The Texas Tribune

The new COVID boosters are coming: Here's what you need to know

Updated versions of the mRNA vaccines roll out this week. Experts say they offer good protection against current COVID variants. Who should get them, and when's the best time to roll up your sleeve?

WEKU

US health agency recommends updated COVID boosters, President Biden calls it "important" milestone

he US health agency Centers for Disease Control and Prevention (CDC) on Tuesday authorized, approved, and recommended everyone 6 months and older get an updated COVID-19 booster.

Dynamite News

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

CDC greenlights two updated COVID-19 vaccines, but how will they fare against the latest variants? 5 questions answered

On Sept. 12, 2023, the Centers for Disease Control and Prevention recommended the newly formulated COVID-19 vaccines for all Americans ages 6 months and up, hours after its expert advisory committee voted 13 to 1 in favor of recommending the vaccines.

The Independent UK

Girl, 7, diagnosed with rare and fatal illness after a routine eye exam

Children with Batten disease suffer seizures, vision loss, and difficulty moving and thinking

WEKU

Kentuckians can access FDA, CDC approved new COVID vaccine targeting Omicron subvariants in coming d

As new variants of COVID are making the rounds, the Food and Drug Administration and Centers for Disease Control and Prevention have approved a new round of COVID-19 vaccines.

WEKU

CDC advisers back broad rollout of new COVID boosters

A panel of doctors and scientists advising the Centers for Disease Control and Prevention voted to recommend that people 6 months of age and older get new COVID boosters this fall.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Can Neurocrine Erase Its Recent Setbacks With This Jump To An Eight-Month High?

Neurocrine said Tuesday its experimental drug could help lower steroid use for patients with a rare, adrenal disease. NBIX stock surged.

Evening Standard

Sarah Beeny underwent gene testing after breast cancer battle to find out family’s risk of developing disease

Sarah Beeny has revealed she underwent genetic testing to determine her family’s risk of developing cancer following her breast cancer battle.

Investors Business Daily

The Surprising Acelyrin News That Sent Rival MoonLake, A Top 1% Stock, Soaring 10%

MoonLake shares rocketed Tuesday after rival Acelyrin reported a failure for its skin disease treatment. MLTX stock neared a record.

The Conversation

How evasive and transmissible is the newest omicron offshoot, BA.2.86, that causes COVID-19? 4 questions answered

The latest variant, or sublineage, of SARS-CoV-2 to emerge on the scene, BA.2.86, has public health experts on alert as COVID-19 hospitalizations begin to rise and the new variant makes its way across the globe.

The National (Scotland)

Scottish experts to help present disease-detecting technology at United Nations event

A pioneering programme involving a University of Glasgow professor is aiming to bring disease detection tech to Sub-Saharan Africa.

WEKU

Australia weighs cat curfews and neutering requirements to rein in feral felines

Tanya Plibersek, Australia's Minister for the Environment and Water, declared "war" on feral cats officials say harm other species and carry disease. Critics say the feline threat is overblown.

The Independent UK

COPD cure could come from transplanting patient’s own lung cells, say scientists

Researchers have shown damaged lung tissue can be repaired in a small number of patients.

1 … 103 104 105 106

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

University of Glasgow

137 stories

the Food and Drug Administration

126 stories

AbbVie Inc

115 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.